No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis

INTRODUCTION: No head-to-head trials have compared the efficacy of the oral therapies, fingolimod, dimethyl fumarate and teriflunomide, in multiple sclerosis. Statistical modeling approaches, which control for differences in patient characteristics, can improve indirect comparisons of the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Richard, Bergvall, Niklas, Tomic, Davorka, Sfikas, Nikolaos, Cutter, Gary, Giovannoni, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245493/
https://www.ncbi.nlm.nih.gov/pubmed/25414048
http://dx.doi.org/10.1007/s12325-014-0167-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245493/
https://www.ncbi.nlm.nih.gov/pubmed/25414048
http://dx.doi.org/10.1007/s12325-014-0167-z

Ejemplares similares